Skip to content
Beacon

LABXTradr 2X Long ALAB Daily ETF

Take a betNewRanked #271 of 948 in this goal

Seeks daily investment results that correspond to 200% of the daily performance of Astera Labs Inc.

By AXS · Launched 2025

Annual Cost

1.30%

#5,557 of 5,853 · expensive

Fund Size

$136M

#2,702 of 5,853 · mid-size

Return (1Y)Goal

N/A

Track Record

12 months

#4,562 of 5,853 · young

Performance

Total-return NAV · USD
Growth of $10,000
$9,149-8.5%

Total-return NAV, USD. Net of fund fees, before tax.

What's inside

How Beacon categorizes this fund

Asset class

Equity

Strategy

Leveraged

What it actually holds

By weight

Concentration

single-stock bet — holdings shown are derivatives collateral, not diversification

CFD ASTERA LABS INC
-40.0%

Asset allocation

Stocks
119.1%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
N/A
Max drawdown
-90.9%Severe

Worst peak-to-trough loss

Sharpe (3Y)
Unavailable

Needs 3+ years of history

Sortino (3Y)
Not yet

Needs 3+ years of history

Listing

Exchange
Cboe BZX, NYSE American

Full fund details

Objective
Seeks daily investment results that correspond to 200% of the daily performance of Astera Labs Inc.
Strategy
Actively manages a portfolio to achieve 200% daily exposure to the common shares of Astera Labs Inc. through swaps and options. Concentrated in the Tech Hardware & Semiconductors industry, with at least 80% exposure to leveraged financial instruments.
Inception date
August 11, 2025
Fund family
AXS

Our take

Structural notes on how this fund behaves. Read our guide on the 6 warning signs.

Leveraged single stock
Critical

Most of these lose money

These funds amplify one stock's daily move, then reset every day. More than half of them have lost money outright, and the daily reset plus financing costs drag roughly 9.5% a year off the return. The longer you hold, the more that compounding works against you.

Sources: Bessembinder, 'Leveraged Single-Stock ETFs' (SSRN 2025)

Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More

What's next?

You've looked at LABX. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.

See other funds for this goal

Data updated on 2026-08-02